文献速递认知障碍与痴呆

中年性激素结合球蛋白水平与老年男女性内tau蛋白神经影像标志物的关联

Midlife Steroid-Binding Globulin Levels and In Vivo Neuroimaging Measures of Tau in Older Men and Women.
PubMed 文献 · Ann Neurol · 2025-06-14

线性回归分析显示,男性中年期较高的SHBG水平与老年期多个脑区较低的tau-PET信号相关,且该关联主要由APOEε4非携带者驱动;睾酮水平与Aβ-PET或tau-PET信号无显著关联。

要点

  • 中年男性较高SHBG水平与老年期内嗅皮层、下颞叶及额中回rostral区较低的tau-PET负担相关。
  • 该关联主要由APOEε4非携带者驱动,睾酮水平与Aβ或tau-PET信号无关。
  • SHBG可能通过血管保护通路降低老年期tau蛋白沉积风险。

核心结论

  • 在临床健康的老年男性中,中年期较高的SHBG水平与晚年较低的tau-PET负担相关,提示潜在保护作用。

研究设计与样本

  • 2002至2005年采集血样检测激素,2016至2020年进行单次Aβ-PiB-PET和18F-Flortaucipir-PET扫描。
  • 采用线性回归分析,按性别分层,校正年龄,并分别检验Aβ-PET和APOEε4的调节效应。

主要发现

  • 男性中,较高的SHBG水平与内嗅皮层tau-PET较低相关(B非标准化=-0.001,SE=0.0005,p=0.007)。
  • 男性中,较高的SHBG水平与下颞叶tau-PET较低相关(B非标准化=-0.001,SE=0.0004,p=0.04)。
  • 男性中,较高的SHBG水平与额中回rostral区tau-PET较低相关(B非标准化=-0.001,SE=0.0004,p=0.02)。
  • 上述关联主要由APOEε4非携带者驱动;睾酮水平与Aβ-PET或tau-PET信号无显著关联。

临床怎么用

  • 中年男性SHBG水平可能作为晚年tau蛋白沉积风险的潜在生物标志物,尤其在高危APOEε4非携带者中。
  • SHBG受可改变的生活方式因素调节,提示通过干预血管相关共病可能影响tau病理。

局限性

  • 单次PET扫描无法评估纵向变化;观察性设计不能确立因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In men and women, sex steroid hormones have been associated with increased risk of Alzheimer's disease (AD) dementia. We aimed to investigate the influence of midlife testosterone and sex hormone binding globulin (SHBG) levels on later-life in vivo markers of β-amyloid (Aβ) and tau deposition in clinically healthy older men. METHODS: This time-lagged study includes participants enrolled in the Framingham Heart Study (FHS) Third Generation cohort. One hundred fifty-nine men (mean agePET-scan = 58 [±/9] years) underwent blood (hormones) collection in 2002 to 2005, and then a single Aβ 11C-Pittsburgh Compound B (PiB) PiB-positron emission tomography (PET) and 18F-Flortaucipir (FTP)-PET scan in 2016 to 2020. Linear regressions examined sex-stratified associations among total testosterone, and SHBG with Aβ-PET, and tau-PET after adjusting for age. Separate models examined the moderating effect of Aβ-PET and APOEε4. RESULTS: In men, the elevated SHBG level was associated with lower tau-PET in entorhinal (Bunstandardized = -0.001 [SE = 0.0005], p = 0.007), inferior temporal (Bunstandardized = -0.001 [SE = 0.0004], p = 0.04), and rostral middle frontal regions (Bunstandardized = -0.001 [SE = 0.0004], p = 0.02). These findings were largely driven by APOEε4 non-carriers. Testosterone levels were not associated with the Aβ-PET or tau-PET signal. INTERPRETATION: We report a potential protective effect of SHBG levels on tau-PET burden in men. Higher levels of SHBG have been associated with lower risk of vascular-related comorbidities, such as obesity and diabetes, and is regulated by modifiable lifestyle factors. Given mounting evidence of a link between vascular injury and tauopathy in preclinical AD, our findings suggest an intriguing protective cardiovascular pathway for men against higher tau burden later in life. ANN NEUROL 2025;98:524-532.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Buckley RF, Scott M, McGrath ER, et al. Midlife Steroid-Binding Globulin Levels and In Vivo Neuroimaging Measures of Tau in Older Men and Women. Ann Neurol. 2025. PMID: 40515488. doi:10.1002/ana.27266

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。